Progress toward identifying potential markers for preeclampsia: Role of agonistic autoantibody to the angiotensin II type i receptor

Hypertension

Volumn 55, Issue 2, 2010, Pages 236-237

  Lamarca, Babbette ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CALCINEURIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PLACENTAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

AMINO ACID SEQUENCE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; UTERUS;

EID: 74949111116     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.141465     Document Type: Note

References (15)

1. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359-372.
2. Maynard S, Min JY, Mercahn J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karu-manchi SA. Excess placental soluble Fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
3. Gilbert JS, Babcock SA, Ganger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased sFlt-1 expression. Hypertension. 2007;50:1142-1147.
4. LaMarca BB, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Auoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008;52:1168-1172.
5. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945-952.
6. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation. 2003;107:1632-1639.
7. Dechend R, Homuth V, Wallukat G, Muller DN, Krause M, Dudenhausen J, Haller H, Luft FC. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig. 2006;13:79-86.
8. Thway TM, Shlykov SG, Day MC, Sanborn BM, Gilstrap LC III, Xia Y, Kellems RE. Antibodies from preeclamptic patients stimulate increased intracellular Ca2 + mobilization through angiotensin receptor activation. Circulation. 2004;110:1612-1619.
9. Bobst SM, Day MC, Gilstrap LC III, Xia Y, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens. 2005;18:330-336.
10. LaMarca B, Parrish M, Ray L, Murphy S, Roberts L, Glover P, Wallukat G, Wenzel K, Cockrell K, Martin JN Jr, Ryan MJ, Dechend R. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension. 2009;54: 905-909.
11. Zhou CC, Ahmad S, Mi T, Abbasi S, Xia L, Day MC, Ramin SM, Ahmed A, Kellems RE, Xia Y. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension. 2008;51:1010-1019.
12. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autanti-bodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14: 855-862.
13. Parrish MR, Murphy SR, Keiser S, Ray LF, Dechend R, Martin JN, Granger JP, LaMarca B. Soluble fms-like tyrosine-1 (sFlt-1) production is enhanced during hypertension in response to tumor necrosis factor-alpha (TNF-a) and agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) [abstract]. Presented at the Central Association of Obstetricians and Gynecologists Meeting; October 25-28, 2009; Maui, Hawaii.
14. Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab. 2006;91:2424-2427.
15. Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension. 2010;55: 386-393.